Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
In this randomized trial, standard treatment of rifampin and isoniazid for 24 weeks plus pyrazinamide and ethambutol for the initial 8 weeks was compared with an initial treatment of bedaquiline–linezolid for 8 weeks, extended treatment for persistent clinical disease, monitoring after treatment, and retreatment for relapse. The shorter approach was determined to be non-inferior.
Family Medicine/General Practice March 2nd 2023